DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Blank A, Markert C, Hohmann N. , et al.
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B.

J Hepatol 2016;
65 (03) 483-489

Download Bibliographical Data

Access:
Access:
Access: